Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
NIC Inc is a software-application business based in the US. NIC shares (EGOV) are listed on the NASDAQ and all prices are listed in US Dollars. NIC employs 1,025 staff and has a trailing 12-month revenue of around USD$460.5 million.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced investors
52-week range | USD$15.2704 - USD$35.2575 |
---|---|
50-day moving average | USD$30.9141 |
200-day moving average | USD$24.7983 |
Wall St. target price | USD$30.67 |
PE ratio | 34.2426 |
Dividend yield | USD$0.36 (1.04%) |
Earnings per share (TTM) | USD$1.01 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing NIC stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of NIC's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
NIC's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, NIC shares trade at around 34x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
NIC's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.36. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into NIC's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
NIC's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$101.7 million.
The EBITDA is a measure of a NIC's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | USD$460.5 million |
---|---|
Operating margin TTM | 18.99% |
Gross profit TTM | USD$165.7 million |
Return on assets TTM | 13.22% |
Return on equity TTM | 25.45% |
Profit margin | 14.9% |
Book value | $4.373 |
Market capitalisation | USD$2.3 billion |
TTM: trailing 12 months
There are currently 1.1 million NIC shares held short by investors – that's known as NIC's "short interest". This figure is 15% down from 1.3 million last month.
There are a few different ways that this level of interest in shorting NIC shares can be evaluated.
NIC's "short interest ratio" (SIR) is the quantity of NIC shares currently shorted divided by the average quantity of NIC shares traded daily (recently around 855982.94573643). NIC's SIR currently stands at 1.29. In other words for every 100,000 NIC shares traded daily on the market, roughly 1290 shares are currently held short.
However NIC's short interest can also be evaluated against the total number of NIC shares, or, against the total number of tradable NIC shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NIC's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 NIC shares in existence, roughly 20 shares are currently held short) or 0.0229% of the tradable shares (for every 100,000 tradable NIC shares, roughly 23 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against NIC.
Find out more about how you can short NIC stock.
Dividend payout ratio: 35.64% of net profits
Recently NIC has paid out, on average, around 35.64% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.05% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), NIC shareholders could enjoy a 1.05% return on their shares, in the form of dividend payments. In NIC's case, that would currently equate to about $0.36 per share.
While NIC's payout ratio might seem fairly standard, it's worth remembering that NIC may be investing much of the rest of its net profits in future growth.
NIC's most recent dividend payout was on 17 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 2 March 2021 (the "ex-dividend date").
Over the last 12 months, NIC's shares have ranged in value from as little as $15.2704 up to $35.2575. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NIC's is 0.2636. This would suggest that NIC's shares are less volatile than average (for this exchange).
NIC Inc., together with its subsidiaries, provides digital government services and payment solutions that enable governments to use technology to provide various services to businesses and citizens in the United States. The company operates through three segments: State Enterprise, Payments, and TourHealth. Its digital government services consist websites and applications that enable businesses and citizens to access government information through online channels, such as applying for a permit, retrieving government records, filing a government-mandated form or report, and making digital payments. The company's service offerings include business registrations and renewals; court services; driver's license renewal; health professional license services; hunting and fishing licenses; income and property tax payments; limited criminal history searches; motor vehicle driver history record retrieval; motor vehicle inspections; payment processing; prescription drug monitoring; professional license renewal; secretary of state business searches; temporary vehicle tags; uniform commercial code searches and filings; vehicle title, lien, and registration; and vital records. Its software & services business provides SaaS solutions relating to payment processing, healthcare and licensing, COVID-19 testing solutions, software development, and other digital government services under state enterprise contracts to federal, state, and local governments. In addition, the company develops and manages the pre-employment screening program for motor carriers using transaction-based business model. NIC Inc. was founded in 1992 and is headquartered in Olathe, Kansas.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.